Re-defining neurological syndromes: The genotype meets the phenotype

Annals of the Academy of Medicine Singapore

Volumn 35, Issue 2, 2006, Pages 63-65

  Tan, Eng King ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

CLINICAL FEATURE; CLINICAL MEDICINE; CLINICAL PRACTICE; DEGENERATIVE DISEASE; DISEASE CLASSIFICATION; EDITORIAL; FRAGILE X SYNDROME; GENE MUTATION; GENETIC COUNSELING; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MEDICAL PRACTICE; MEDICAL STUDENT; MOLECULAR GENETICS; NEUROLOGIC DISEASE; NUCLEOTIDE REPEAT; PARKINSON DISEASE; PHENOTYPE; PHYSICIAN; PRACTICE GUIDELINE; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT;

EID: 33646685919     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. Genetic testing and genetic research: a report by the bioethics advisory committee, Singapore, Nov 2005. Available at: http://www.biomed-singapore.com. Accessed date?
2. Tan EK. Autosomal dominant spinocerebellar ataxias: an Asian perspective. Can J Neurol Sci 2003;30:361-7.
3. Tan EK, Ashizawa T. Genetic testing in spinocerebellar ataxias: defining a clinical role. Arch Neurol 2001;58:191-5.
4. Zhao Y, Tan EK, Law HY, Yoon CS, Wong MC, Ng I. Prevalence and ethnic differences of autosomal-dominant cerebellar ataxia in Singapore. Clin Genet 2002;62:478-81.
5. Furtado S, Payami H, Lockhart PJ, Hanson M, Nutt JG, Singleton AA, et al. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 2004;19:622-9.
6. Shan DE, Liu RS, Sun CM, Lee SJ, Liao KK, Soong BW. Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: clinical implications. Mov Disord 2004;19:1357-60.
7. Gwinn-Hardy K, Chen JY, Liu HC, Liu TY, Boss M, Seltzer W, et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 2000;55:800-5.
8. Tan EK, Zhao Y, Puong KY, Law HY, Chan LL, Yew K, et al. Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology 2004;63:362-3.
9. Willemsen R, Mientjes E, Oostra BA. FXTAS: a progressive neurologic syndrome associated with Fragile X premutation. Curr Neurol Neurosci Rep 2005;5:405-10.
10. Hall DA, Berry-Kravis E, Jacquemont S, Rice CD, Cogswell J, Zhang L, et al. Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXT AS). Neurology 2005;65:299-301.
11. Erratum in: Neurology 2005;65:784.
12. Tan EK, Jankovic J. Genetic testing in parkinson's disease: promises and pitfalls. Arch Neurol (in press)
13. Skipper L, Li Y, Bonnard C, Pavanni R, Yih Y, Chua E, et al. Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. Hum Mol Genet 2005;14:3549-56.
14. Skipper L, Shen H, Chua E, Bonnard C, Kolatkar P, Tan LC, et al. Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology 2005;65:1319-21.
15. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-7.
16. Tan EK, Shen H, Tan LC, Farrer M, Yew K, Chua E, et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease. Neurosci Lett 2005;384:327-9.
17. Khalik S, Chang AL. Many won't want to take part in big health study. The Straits Times, January 7, 2006:1.